Skip to main content

Table 1 Patient characteristics in sarcopenia substudy and whole SAKK 75/08 population

From: Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy

 

SAKK 75/08

whole population

Sarcopenia substudy population

n

300

61

Age (years; median and range)

61 (36, 75)

61 (38, 75)

Sex

 Female

37 (12.3%)

4 (6.6%)

 Male

263 (87.7%)

57 (93.4%)

Clinical stage

 T2 N+

44 (14.7%)

16 (26.2%)

 T3 N0

31 (10.3%)

2 (3.3%)

 T3/4 N+

225 (75.0%)

43 (70.5%)

Performance Status

 0

189 (63.0%)

32 (52.5%)

 1

109 (36.3%)

29 (47.5%)

Histologic Type

 AC

189 (63.0%)

50 (82.0%)

 SCC

111 (37.0%)

11 (18.0%)

  1. AC Adenocarcinoma, SCC Squamous cell carcinoma. Baseline L3 muscle index was not assessable in one patient